CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme
Simona Daniele, Valeria La Pietra, Rebecca Piccarducci, Deborah Pietrobono, Chiara Cavallini, Vincenzo Maria D’Amore, Linda Cerofolini, Stefano Giuntini, Pasquale Russomanno, Michela Puxeddu, Marianna Nalli, Martina Pedrini, Marco Fragai, Claudio Luchinat, Ettore Novellino, Sabrina Taliani, Giuseppe La Regina, Romano Silvestri, Claudia Martini, Luciana Marinelli
Topics & Concepts
AntagonismGlioblastomaIndole testCancer researchCXCR4CancerMdm2ChemistryMedicinePharmacologyBiologyStereochemistryInternal medicineBiochemistryGeneReceptorChemokineChemokine receptors and signalingCancer Mechanisms and TherapyCAR-T cell therapy research